BAT Tests Find Overfilled E-Cigarette Liquids in UK Market

Mar.17.2023
BAT Tests Find Overfilled E-Cigarette Liquids in UK Market
A test by BAT found most major disposable e-cigarette brands in the UK have overfilled e-liquid, according to betterRetailing.

On March 17th, UK media outlet betterRetailing released a report on BAT (British American Tobacco) testing, which revealed that almost all major disposable e-cigarette brands in the UK had exceeded the legal limit for nicotine content in their e-liquids. This included popular UK brands such as Elfbar, LOSTMARY, SMOK, SKE Crystal, and Solo. BAT sent the results of the testing report to distributors, retailers, and regulatory bodies, urging them to ensure that non-compliant products were not supplied.


The President of UKVIA, John...


In response to this incident, 2FIRSTS conducted an email interview with the President of the UK Vaping Industry Association (UKVIA), John. The original interview in English can be accessed by clicking the provided link. The following is the full transcript of the interview.


Can you provide the English translation of "Q:2FIRSTS"? It is unclear what you are referring to.


A spokesperson for the UK Vaping Industry Association (UKVIA), John


According to a report from Better Retailing, British American Tobacco conducted testing on disposable e-cigarette liquid in the UK market and sent the results to distributors and government departments. Has the association been made aware of this news? Did British American Tobacco send the testing report to the association?


BAT has conducted numerous tests on disposable e-cigarette brands in the UK and shared its findings with various organizations, including the association. It is also known that other companies have conducted similar tests, but their results differ from those of BAT.


Do you believe that the issue of "e-cigarette e-liquid exceeding standards" is a common problem in the UK e-cigarette market?


A: Yes, based on the data we have seen, we do believe that some brands have been using excessive amounts of e-liquid to gain a competitive advantage.


Question: Will this test result regarding the excessive levels found in disposable e-cigarettes have an impact on the disposable e-cigarette market in the UK?


A: Yes, I believe this highlights issues with the MHRA approval process. I expect this process to become more rigorous. Additionally, I think major distributors should now perform their own testing on products they bring in. Non-compliant behavior is unacceptable.


Several brand dealers have said that some of the products tested by BAT are "old inventory," while the latest products are now compliant with standards. Will UKVIA test the latest products?


A: The key issue is not the inventory itself, as "old stock" is not a legitimate excuse. In fact, it's quite simple - products are either compliant or non-compliant. I believe all brands should conduct regular testing to ensure they are following the rules. The association will not protect those who break the law.


Q: Has BAT been in contact with the association and asked them to take measures?


Yes, we have had multiple discussions with BAT regarding this issue. If the MHRA and trade transaction standards are the regulators and enforcers in this matter, we will work with both institutions to ensure that the products sold in the UK are legal. The association will also protect its good reputation.


Special Statement: The above content is a translated article, for accurate interpretation please refer to the original English version.


Click here to read the original article in English: UKVIA responds to overfill incident, alleging that BAT's findings contradict tests conducted by other companies.


Further reading:


Content summary of the ELFBAR over-the-limit e-liquid incident in the UK.


British media reports obtaining BAT test report: Almost all disposable e-cigarette brands in the UK have excessive e-liquid levels.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Indonesian Health Ministry Says New Vape Rules Will Cover Age Limits, Advertising, and Product Standards
Indonesian Health Ministry Says New Vape Rules Will Cover Age Limits, Advertising, and Product Standards
Indonesia’s Ministry of Health is preparing to implement regulations on electronic cigarettes, as provided for in Government Regulation No. 28 of 2024. The ministry said e-cigarettes will be regulated under provisions equivalent to those applied to conventional cigarettes, including age restrictions, advertising controls, product content standards, pictorial health warnings, and bans on use in smoke-free areas.
Apr.16 by 2FIRSTS.ai
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
On April 22, 2026, Philip Morris International released its first-quarter 2026 results. The report showed net revenues of $10.146 billion, up 9.1% year on year; adjusted diluted EPS of $1.96, up 16.0%; and smoke-free products accounting for 43% of total net revenues. Based on first-quarter performance, the company raised its 2026 full-year adjusted diluted EPS forecast to $8.36 to $8.51, or $8.11 to $8.26 excluding currency.
Apr.23 by 2FIRSTS.ai
 Bangladesh Approves Amended Tobacco Control Law Expanding Ad Bans and Smoke-Free Areas
Bangladesh Approves Amended Tobacco Control Law Expanding Ad Bans and Smoke-Free Areas
Bangladesh’s new government has approved a broad tobacco control amendment that bans tobacco advertising, promotion and display across print, electronic, digital and social media, entertainment platforms and points of sale. The law does not cover newer products such as vapes, heated tobacco products, electronic nicotine delivery systems or nicotine pouches.
Apr.22 by 2FIRSTS.ai
Innovation, Insights and Networking: NUBIZ Brings the Global NGP Industry Together in Dortmund
Innovation, Insights and Networking: NUBIZ Brings the Global NGP Industry Together in Dortmund
The market for next-generation products is expanding rapidly, with vapes, e-cigarettes, pouches, snus and heat-not-burn products among the industry’s most innovative segments. As part of InterTabac, NUBIZ provides a central platform for reduced-risk tobacco and nicotine products, bringing together global leaders and newcomers from 15 to 17 September. The show combines market insights, product comparisons, networking, a high-level conference programme and exclusive side events.
Jun.03
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai